Recent Developments in Pharmacotherapy of Depression: Bench to Bedside

For the last 70 years, we did not move beyond the monoamine hypothesis of depression until the approval of the S-enantiomer of ketamine, an N-methyl-D-aspartate (NMDA) receptor blocker and the first non-monoaminergic antidepressant characterized by rapid antidepressant and antisuicidal effects. A si...

Descripción completa

Detalles Bibliográficos
Autor principal: Shad, Mujeeb U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223297/
https://www.ncbi.nlm.nih.gov/pubmed/37240943
http://dx.doi.org/10.3390/jpm13050773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223297/
https://www.ncbi.nlm.nih.gov/pubmed/37240943
http://dx.doi.org/10.3390/jpm13050773

Ejemplares similares